Speeches & presentations

David Redfern

David Redfern, Chief Strategy Officer, discusses the two transactions with Bristol-Myers Squibb to acquire their late-stage HIV pipeline assets and also their pre-clinical and discovery stage research assets.

• ViiV-BMS investor transcript PDF - 173.8KB

R&D event

On Tuesday 3 November, we hosted an event focusing on our R&D pipeline. This provided a unique insight into the innovative medicines and vaccines that GSK is developing for the future.

• R&D event full presentation PDF - 4.3MB
• R&D event full transcript PDF - 528.4KB
• R&D event Andrew Witty introduction presentation PDF - 564.2KB
• R&D event Andrew Witty introduction transcript PDF - 37.7KB
• Dr Patrick Vallance HIV, infectious diseases, respiratory, PHI presentation PDF - 1.6MB
• Dr Patrick Vallance HIV, infectious diseases, respiratory, PHI transcript PDF - 238.2KB
• Dr Patrick Vallance immuno-inflammation, oncology, rare diseases presentation PDF - 2.0MB
• Dr Patrick Vallance immuno-inflammation, oncology, rare diseases transcript PDF - 168.1KB
• Dr Moncef Slaoui vaccines business presentation PDF - 736.7KB
• Dr Moncef Slaoui vaccines business transcript PDF - 101.3KB

Investor event

The Investor event outlined the Group’s strategy for 2015 and beyond including presentations from the heads of our Vaccines, Pharmaceuticals and Consumer businesses together with Sir Andrew Witty, Chief Executive Officer and Simon Dingemans, Chief Financial Officer.

• Investor event full presentation PDF - 3.0MB
• Investor event full transcript PDF - 305.5KB
• Andrew Witty strategic outlook presentation PDF - 382.0KB
• Andrew Witty strategic outlook transcript PDF - 35.9KB
• Dr Moncef Slaoui vaccines business presentation PDF - 949.9KB
• Dr Moncef Slaoui vaccines business transcript PDF - 67.0KB
• Abbas Hussain pharmaceuticals business presentation PDF - 890.5KB
• Abbas Hussain pharmaceuticals business transcript PDF - 44.2KB
• Emma Walmsley consumer healthcare presentation PDF - 1.4MB
• Emma Walmsley consumer healthcare transcript PDF - 41.9KB
• Simon Dingemans financial outlook presentation PDF - 321.3KB
• Simon Dingemans financial outlook transcript PDF - 37.9KB

33rd Annual JP Morgan Healthcare Conference

David Redfern, Chief Strategy Officer, gave a presentation at the 33th Annual JP Morgan Healthcare Conference in San Francisco.

• 33rd Annual JP Morgan healthcare conference full presentation PDF - 1.4MB
• 33rd Annual JP Morgan healthcare conference full transcript PDF - 98.3KB

Bank of America Merrill Lynch Global Healthcare Conference, London UK

Simon Dingemans, Chief Financial Officer, gave a presentation at the Bank of America Merrill Lynch Global Healthcare conference in London on 19th September 2014. Simon provided an overview of the recent results and the shape of the company going forward.

• Bank of America healthcare conference PDF - 683.3KB

Investor Event at ERS 2014, Munich

Darrell Baker, Senior Vice President, Head of Global Respiratory Franchise hosted an investor event comprising a presentation and Q&A session based on data presented at ERS.

• ERS investor briefing presentation PDF - 1.0MB
• ERS investor briefing transcript PDF - 327.3KB

Citi Global Healthcare Conference, New York USA

Andrew Witty, CEO, presented at the Citi Global Healthcare Conference on February 24, 2014 in New York. Andrew opened with a few minutes of brief remarks followed by a 'fireside chat' question and answer session.

32nd Annual JP Morgan Healthcare Conference, San Francisco USA

Simon Dingemans, Chief Financial Officer, gave a presentation at the 32nd Annual JP Morgan Healthcare Conference in San Francisco. Simon provided an overview of the progress being made in implementing the company’s strategy.

• JP Morgan healthcare conference 2014 presentation PDF - 555.9KB
• JP Morgan healthcare conference 2014 transcript PDF - 83.6KB
• JP Morgan healthcare conference 2014 transcript Q&A PDF - 114.2KB

Leerink Swann PolarXpress, Philadelphia

Dr Paolo Paoletti, President of GSK Oncology, hosted an investor event organized by Leerink Swann at the GSK offices in Philadelphia.

• Leerink Swann polarxpress 2013 PDF - 1.9MB

North Carolina CEO Forum

Deirdre Connelly, President, North America Pharmaceuticals, spoke at the North Carolina CEO Forum about the importance of curiosity, vision, flexibility, and risk-taking to create a high-performing, innovative, and sustainable business.

• North Carolina CEO forum speech 2013 PDF - 74.0KB

Goldman Sachs 34th Annual Global Healthcare Conference, California USA

David Redfern, Chief Strategy Officer, gave a fireside chat on GSK’s business strategy and addressed questions in front of a large group of US investors at the Goldman Sachs Conference in California on Wednesday 12 June 2013.

Investor Event at ATS 2013, Philadelphia

Darrell Baker, Senior Vice President, Head of Global Respiratory Franchise hosted an investor event comprising a short presentation and Q&A session based on data presented at ATS.

• ATS analyst and investor event 2013 PDF - 998.9KB

Leerink Swann Healthcare Conference

Simon Dingemans, Chief Financial Officer, addressed questions in front of a large group of US investors at the Leerink Swann Global Healthcare Conference on Wednesday, February 13 in New York.  Simon provided an overview of GSK’s 2012 full year results and outlook for the future.

Late-stage pipeline review - Patrick Vallance

Patrick Vallance, President, Pharmaceutical R&D gave a presentation at the 31st Annual JP Morgan Healthcare Conference in San Francisco. Patrick provided a review of the progress being made on the late stage pipeline.

• Late stage pipeline review 2013 PDF - 664.5KB

Late-stage pipeline review - Sir Andrew Witty, Dr Moncef Slaoui, and Dr Patrick Vallance

Sir Andrew Witty (CEO), Dr Moncef Slaoui (Chairman of R&D) and Dr Patrick Vallance (President of Pharmaceutical R&D) together with senior R&D leaders hosted a seminar focusing on GSK’s late stage pipeline. The event brought together the progress made in 2012, as Phase III programmes for a significant number of potential new drugs have concluded. It also provided an overview of our progress on our returns driven strategy in R&D and the sustainability of our pipeline.

• Late stage pipeline review PDF - 2.1MB

Annual Pharmaceutical Regulatory and Compliance Congress

Deidre Connelly, President North America Pharmaceuticals, spoke at the 13th Annual Pharmaceutical Regulatory and Compliance Congress about how we conduct our business.

• GSK Deirdre Connelly pharmEHR summit speech 21 March 2012 PDF - 108.7KB

Investor Meeting at ESMO, Vienna

Dr Paolo Paoletti, President of GSK Oncology, hosted an investor event in conjunction with data presented at the European Society for Medical Oncology.

• ESMO analyst presentation 1 Oct 2012 PDF - 573.3KB

Investor Meeting at IAC, Washington

ViiV Healthcare Chairman David Redfern, CEO Dominique Limet and Chief Scientific and Medical Officer, John Pottage, hosted an investor event at the International AIDS Conference (IAC).

• IAC analyst presentation PDF - 471.5KB

Investor Meeting at ADA, Philadelphia

Dr Carlo Russo, Senior Vice President and Head of Albiglutide Development hosted an investor event in conjunction with data presented at the American Diabetes Association meeting.

• Ada analyst meeting 2012 PDF - 290.3KB

Investor Meeting at ASCO, Chicago

Paolo Paoletti, President of GSK Oncology, hosted an investor event in conjunction with data presented at the American Society of Clinical Oncology (ASCO) meeting.